A home services entrepreneur's plan to slash personal profits to fund significant pay raises for staff has ignited a fierce debate on Reddit's r/smallbusiness, highlighting the complex calculus between generosity, motivation, and sustainable growth.
Baron Discovery Fund's latest investor letter spotlights Exact Sciences (EXAS) as a key contributor, buoyed by strong market adoption of its cancer screening tests and favorable industry dynamics, despite the fund's broader quarterly underperformance.
Terns Pharmaceuticals has renegotiated its licensing deal for TERN-701, gaining exclusive worldwide rights outside key Asian markets. The strategic move comes after a period of explosive stock performance, but analysts are now scrutinizing whether its premium valuation is justified given its clinical-stage pipeline and lack of revenue.
Cognex Corporation (CGNX) shares have shown recent strength, closing at $39.76. While the stock gained 7.7% over the past month, it remains down sharply over three and five-year horizons, presenting investors with a complex valuation puzzle amid shifting industrial automation trends.
As economic forecasts shift, five established Nasdaq 100 companies offering substantial dividends are drawing attention from investors prioritizing income and capital preservation for the coming years.
AbbVie moves to bolster its pipeline through the acquisition of Capstan Therapeutics for its in vivo CAR-T platform and a regulatory push to expand RINVOQ into vitiligo treatment, signaling a strategic pivot towards complex immunology and oncology.
Uber has relaunched its ride-hailing services in Macau after a multi-year hiatus, introducing a key cross-border limousine link to Hong Kong. The move tests the company's strategy in a competitive Greater China-linked market and its push into higher-margin services.
Recent volatility in Genscript Biotech's (SEHK:1548) share price has investors questioning its true worth. While short-term gains offer a glimmer, a deeper look reveals a stark three-year decline, setting the stage for a critical valuation debate.
Shares of energy and industrial distributor DNOW Inc. have rallied sharply, gaining over 16% year-to-date. With the stock closing at $15.56, analysts and investors are divided: does a reported intrinsic value of $17 signal a buying opportunity, or do premium earnings multiples and sector headwinds suggest caution?
Rio Tinto shares have delivered stellar returns over the past year, but a deep dive into valuation metrics suggests the market may still be underestimating the diversified miner's intrinsic value. We analyze the numbers behind the rally.
Financial technology giant Broadridge Financial Solutions (NYSE: BR) reported fourth-quarter revenue and profit that comfortably exceeded Wall Street forecasts, driven by resilient demand for its core transaction processing and investor communications services.
Dell Technologies and Indian IT firm NxtGen AI have announced a strategic collaboration to establish what is being billed as India's premier AI factory. The initiative leverages Dell's AI Factory architecture with NVIDIA technology, aiming to provide scalable AI infrastructure for enterprises, startups, and government agencies across the country.
While broader markets edged higher, shares of Merck and Pfizer fell Tuesday following their quarterly results, underscoring the strategic pivots and patent-cliff pressures quietly reshaping the pharmaceutical industry.
The appointment of former Virginia Attorney General Richard Cullen to TowneBank's board has shifted investor focus to the regional lender's governance and premium valuation. While recent financial performance shows strength, analysts debate whether the stock's current price fully reflects its growth prospects and regional risks.
Voya Financial reaffirms its commitment to shareholders with a new quarterly dividend and expanded share repurchase program, while simultaneously investing in brand growth through a multi-year partnership with NWSL's Boston Legacy FC.
PepsiCo reported stronger-than-expected Q4 2025 revenue of $29.34 billion, a 5.6% year-over-year increase. However, a continued drop in sales volumes and margin pressures highlight the challenges facing the consumer staples giant as it navigates a shifting market.
Despite trailing the broader market over the past year, Intercontinental Exchange (ICE) retains robust analyst confidence, with a 'Strong Buy' consensus and significant projected upside ahead of its upcoming earnings.
As streaming prices climb and household budgets tighten, Americans are finding their finances quietly drained by forgotten subscriptions. Experts reveal practical strategies to audit, bundle, and cancel services without sacrificing entertainment.
A new analysis from Macquarie reveals a pivotal shift: carbon pricing is now being driven more by local political will and regulatory changes than by global emissions trends, creating divergent fortunes for markets from Europe to the Pacific.
A new analysis reveals a surge in Gulf investment in African clean energy projects, while urging a strategic pivot towards funding the continent's underdeveloped power grids to unlock greater economic and climate impact.
